Brought to you by 
Valeant pays $312mm for OraPharma plus potential $114mm in earn-outs
05 Jul 2012
Executive Summary
Keeping up its string of acquisitions, Valeant Pharmaceuticals International Inc. is buying closely held oral health company OraPharma Inc. from private equity firm Water Street Healthcare Partners for $312mm in cash up front and up to $114mm in earn-outs based on milestones including revenue targets.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Valeant pays $312mm for OraPharma plus potential $114mm in earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice